Centessa Pharmaceuticals plc (CNTA.D)
- Sector
- Biotechnology
- Last price
- $40.50
- As of
Kresmion compiles this page from CNTA.D's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Centessa Pharmaceuticals plc (CNTA.D): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-06-24.
See the full CNTA.D dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CNTA.D on one page. Preview it with sample data, then open it live with a free account.
Preview the CNTA.D dossierActive signals for CNTA.D
No recent signals on CNTA.D in the last 180 days.
FREE, NO ACCOUNT
Every signal on CNTA.D, as it fires
New filings, 13F moves and cross asset signals on CNTA.D land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, CNTA.D
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CNTA.D against its peers
CNTA.D's operating margin of -1384.6% ranks in the 18th percentile of 13 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | CNTA.D | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 15.0M USD | 266M USD | 32 | 16 |
| Gross margin | n/a | 88.2% | n/a | 6 |
| Operating margin | -1384.6% | -12.8% | 18 | 13 |
| Net margin | -1316.9% | -5.2% | 18 | 13 |
| Return on equity | -37.5% | -26.3% | 41 | 22 |
Peers (24): LGND, RYTM, BLTE, IOVA, MANE, PRAX, GRAL, IMVT, COGT, KOD, IONS, MIRM, ALKS, CGON, APLS.D, PTCT, TVTX, ORKA, SYRE, ERAS, SRRK, ABVX, CRSP, TGTX. Left out: BCHMY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (CNTA.D: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CNTA.D on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CNTA.D for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.